|
|
|
|
|
|
Merck & Company (MRK)
|
|
65.79 -0.16 (-0.24%)
|
9/20/2017 4:02pm
|
|
Open:
|
66.07
|
Pre. Close:
|
65.95
|
|
High:
|
66.31
|
Low:
|
65.19
|
|
Volume:
|
9,450,016
|
Market Cap:
|
179.43B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
66.57 - 67.14
|
67.14 - 67.56
|
|
Low:
|
64.28 - 64.78
|
64.78 - 65.15
|
|
Close:
|
65.21 - 65.99
|
65.99 - 66.57
|
|
|
|
|
|
|
Technical analysis (as of: 2017-09-20 4:40:21 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 77.57 One year: 90.60
|
|
Support:
|
Support1: 63.17 Support2: 61.16
|
|
Resistance:
|
Resistance1:
66.41 Resistance2: 77.57
|
|
Pivot:
|
64.87 
|
|
Moving Averages:
|
MA(5): 66.00 MA(20): 64.37
MA(100): 63.76 MA(250): 63.00
|
|
MACD:
|
MACD(12,26):
0.82  Signal(12,26,9): 0.64
|
|
%K %D:
|
%K(14,3): 86.16 %D(3): 90.00
|
|
RSI:
|
RSI(14): 68.82
|
|
52-Week:
|
High: 66.80
Low: 58.29 Change(%): 4.4
|
|
Average Vol(K):
|
3-Month: 710921
10-Days 478488
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.MRK has closed below upper band by 27.3%. Bollinger Bands are 38.6% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Wed, 20 Sep 2017 15:45:00 GMT
Traders Secrets on Halliburton Company (HAL), Merck & Co., Inc. (MRK)
Wed, 30 Aug 2017 19:07:30 GMT
Merck: Keytruda As A Growth Driver
Wed, 30 Aug 2017 11:37:30 GMT
Merck's Growth Catalyst
Fri, 25 Aug 2017 19:52:30 GMT
Merck: Shareholders will fail to be rewarded here
Tue, 22 Aug 2017 20:37:30 GMT
Diagnosing Merck (Part 1 Of 2)
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
